Sign In

Scott Willoughby

Senior Vice President - General Counsel & Corporate Secretary at Sangamo Therapeutics, Inc.

Professional Background

Scott Bryan Willoughby is a distinguished legal professional serving as the Senior Vice President, General Counsel, and Corporate Secretary at Sangamo Therapeutics, Inc., a leading biotechnology company that specializes in genomic medicines. Based in Brisbane, California, Sangamo Therapeutics focuses its innovative efforts on developing cell therapies for autoimmune disorders and advanced genome engineering therapies for central nervous system diseases. Under Scott's leadership, the legal team has significantly contributed to the company's progress and success in this cutting-edge field. His expertise and dedication to fostering a productive legal environment make him a vital part of Sangamo, as he works alongside some of the most talented innovators in the biotechnology industry.

Education and Achievements

Scott's academic foundation is rooted in his prestigious education at the University of California, Berkeley, where he earned his Juris Doctor (J.D.) at the Berkeley School of Law. His extensive knowledge gained during his legal studies has clearly shaped his rich career in corporate law. Moreover, Scott holds a Bachelor of Arts degree in Political Science and French from the same esteemed institution, highlighting his commitment to a well-rounded education. This diverse educational background equips him with unique perspectives and insights relevant to the legal aspects of the rapidly evolving biotechnology landscape.

Career Journey

Prior to his current role, Scott was instrumental in various high-level legal positions, demonstrating his exceptional capabilities and commitment to corporate law. His career journey includes serving as the Vice President of Corporate Law at Sangamo Therapeutics, where he played a pivotal role in the company's strategic legal initiatives and corporate governance framework. Before advancing to this significant role, he was the Vice President and Deputy General Counsel at Achaogen, where he trained his focus on corporate governance and compliance, further honing his legal expertise.

Scott began his illustrious career in legal practice at McKesson, where he held the position of Senior Counsel in the Mergers & Acquisitions sector. His time at McKesson allowed him to develop significant knowledge in corporate transactions and compliance matters. Furthermore, he expanded his corporate legal proficiency at Uber, where he served as Senior Counsel, Corporate, contributing to the dynamic legal requirements of one of the most recognized brands globally.

Scott's corporate journey also includes a position as Senior Corporate Counsel at The Clorox Company, where he handled varied legal challenges and ensured the company adhered to corporate governance standards. Adding to his remarkable experience, he previously worked as a Senior Associate specializing in Corporate, Securities, and M&A at Latham & Watkins, a leading law firm, where he gained an invaluable understanding of the intricacies in corporate law that he applies to his current role and beyond.

Notable Contributions and Leadership

Throughout his career, Scott has demonstrated his commitment to nurturing and developing high-performing legal teams, fostering collaboration and excellence within his teams. His visionary leadership at Sangamo Therapeutics is evident through his continued focus on providing supportive guidance in navigating complex legal landscapes, which is fundamental for the biotechnology organization's success. Scott’s role is crucial in ensuring that Sangamo Therapeutics continues to lead the way in innovative therapeutic solutions, which have the potential to alleviate severe conditions in patients worldwide.

Scott Bryan Willoughby's comprehensive skill set, refined through rigorous education and demonstrated in diverse roles across various sectors, makes him a sought-after leader in the biotechnology legal space. His proactive approach to legal matters, coupled with his extensive knowledge of compliance and corporate governance, ensures that Sangamo Therapeutics remains at the forefront of genomic medicine advancements. Scott’s career is a testament to his unwavering commitment to creating positive outcomes through legal excellence and innovation.

Related Questions

How did Scott Bryan Willoughby develop his expertise in corporate law and governance?
What notable achievements has Scott Bryan Willoughby accomplished during his time at Sangamo Therapeutics?
In what ways does Scott Bryan Willoughby lead his legal team to navigate the complexities of biotechnology law?
What factors have shaped Scott Bryan Willoughby's approach to legal challenges in the biotechnology industry?
How has Scott's education at UC Berkeley contributed to his professional success as General Counsel?
Scott Willoughby
Add to my network

Location

Brisbane, California, United States